1. Home
  2. KBSX vs NVCT Comparison

KBSX vs NVCT Comparison

Compare KBSX & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KBSX
  • NVCT
  • Stock Information
  • Founded
  • KBSX N/A
  • NVCT 2020
  • Country
  • KBSX Taiwan
  • NVCT United States
  • Employees
  • KBSX N/A
  • NVCT N/A
  • Industry
  • KBSX Recreational Games/Products/Toys
  • NVCT Medicinal Chemicals and Botanical Products
  • Sector
  • KBSX Consumer Discretionary
  • NVCT Health Care
  • Exchange
  • KBSX Nasdaq
  • NVCT Nasdaq
  • Market Cap
  • KBSX 104.0M
  • NVCT 107.8M
  • IPO Year
  • KBSX N/A
  • NVCT 2022
  • Fundamental
  • Price
  • KBSX N/A
  • NVCT $5.49
  • Analyst Decision
  • KBSX
  • NVCT Strong Buy
  • Analyst Count
  • KBSX 0
  • NVCT 1
  • Target Price
  • KBSX N/A
  • NVCT $21.00
  • AVG Volume (30 Days)
  • KBSX N/A
  • NVCT 104.2K
  • Earning Date
  • KBSX N/A
  • NVCT 03-04-2025
  • Dividend Yield
  • KBSX N/A
  • NVCT N/A
  • EPS Growth
  • KBSX N/A
  • NVCT N/A
  • EPS
  • KBSX N/A
  • NVCT N/A
  • Revenue
  • KBSX N/A
  • NVCT N/A
  • Revenue This Year
  • KBSX N/A
  • NVCT N/A
  • Revenue Next Year
  • KBSX N/A
  • NVCT N/A
  • P/E Ratio
  • KBSX N/A
  • NVCT N/A
  • Revenue Growth
  • KBSX N/A
  • NVCT N/A
  • 52 Week Low
  • KBSX N/A
  • NVCT $4.44
  • 52 Week High
  • KBSX N/A
  • NVCT $12.10
  • Technical
  • Relative Strength Index (RSI)
  • KBSX N/A
  • NVCT 49.57
  • Support Level
  • KBSX N/A
  • NVCT $5.34
  • Resistance Level
  • KBSX N/A
  • NVCT $5.89
  • Average True Range (ATR)
  • KBSX 0.00
  • NVCT 0.51
  • MACD
  • KBSX 0.00
  • NVCT 0.02
  • Stochastic Oscillator
  • KBSX 0.00
  • NVCT 33.68

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: